Loading
Clover Biopharmaceuticals, Ltd. - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest was filed 09 Apr 2026.
Clover Biopharmaceuticals, Ltd. - B: what insiders have been doing
Clover Biopharmaceuticals, Ltd. - B belongs to the Health Care sector. Filings by its managers are published through HKEX. In the past year (18 October 2025 to 18 October 2026), 40 filings came from 8 insiders.
Purchases and sales both appear in the filings: 11 purchases (8 insiders) and 19 sales (2 insiders, €720k). The amount is not disclosed for 14 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a sale of €206k from Liang Peng, disclosed on 24 April 2026, or 0.083% of market capitalisation.
Across the 750 companies tracked on its exchange, the median is 5 filings; at 40 filings, this issuer sits above that mark. The full history, which starts in 2026, counts 11 purchases against 19 sales.
The last purchase on record was published on 9 April 2026, which is 192 days ago. Typically, a trade is published a median of 5 days after it takes place. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. Source: insider filings from HKEX. Past trades are no guide to future returns.
Insider Decl.
40
Thresholds
n/a
Buy Volume
n/a
11 ops. · all time
Sell Volume
€719,656
19 ops. · all time
Who traded when
BuySaleLiang Peng2 buys19 sales
Liang Joshua G3 buys1 sale
AMBROSINO Donna Marie1 buy
Farrow Jeffrey Stewart1 buy
Leggett Thomas Edward1 buy
Liao Xiang1 buy
+2 other insiders
Since the insiders bought
- -47.7%Entry HK$3.08 · Close 14 Oct 2026 HK$1.61
- -47.7%Entry HK$3.08 · Close 14 Oct 2026 HK$1.61
- -43.5%Entry HK$2.85 · Close 14 Oct 2026 HK$1.61
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$1.60
Analyst consensus
Income statement
RevenueHK$3.5M
Gross profitHK$2.7M78% margin
EBITDA-HK$177.5M-5064% margin
Net income-HK$205.1M197942.8% margin
Valuation
PER (trailing)2.2x
Beta2.58
Balance sheet & cash
Market capHK$2.1B
Total debtHK$10.6M
Free Cash Flow-HK$194.9M
Profitability & ownership
ROA-44.5%
% insiders34.1%
% institutions15.1%
Last declaration on 15 October 2026
Declarations40 total
100,000 shares@ HK$1.56ShareXHKGHKEX:DA20261015E00093
50,000 shares@ HK$1.80ShareXHKGHKEX:DA20261015E00091
100,000 shares@ HK$1.900.0078% mcap3.1% of flowShareXHKGHKEX:DA20261002E00062
100,000 shares@ HK$2.060.0076% mcap3.4% of flowShareXHKGHKEX:DA20260923E00419
100,000 shares@ HK$2.2450.0082% mcap3.7% of flowShareXHKGHKEX:DA20260914E00054
500,000 shares@ HK$1.800.033% mcap14.9% of flowShareXHKGHKEX:DA20260721E00133
50,000 shares@ HK$1.550.0029% mcap1.3% of flowShareXHKGHKEX:DA20260715E00487
50,000 shares@ HK$1.720.0032% mcap1.4% of flowShareXHKGHKEX:DA20260707E00164
50,000 shares@ HK$1.730.0032% mcap1.4% of flowShareXHKGHKEX:DA20260701E00013
100,000 shares@ HK$1.640.0060% mcap2.7% of flowShareXHKGHKEX:DA20260701E00012
100,000 shares@ HK$1.8110.0066% mcap3.0% of flowShareXHKGHKEX:DA20260629E00014
14,500 sharesShareXHKGHKEX:DA20260617E00208
52,500 shares@ HK$2.4390.0046% mcap2.1% of flowShareXHKGHKEX:DA20260601E00003
47,500 shares@ HK$2.460.0042% mcap1.9% of flowShareXHKGHKEX:DA20260601E00004
600,000 shares@ HK$3.160.083% mcap30.8% of flowShareXHKGHKEX:DA20260424E00084
300,000 shares@ HK$3.120.041% mcap15.1% of flowShareXHKGHKEX:DA20260417E00037
49,000 sharesShareXHKGHKEX:DA20260409E00113
49,000 sharesShareXHKGHKEX:DA20260409E00086
383,000 sharesShareXHKGHKEX:DA20260409E00099
Canonical exit: 1 Jul 2026 (T+90)
1,086,000 sharesShareXHKGHKEX:DA20260409E00098
1,326,875 sharesShareXHKGHKEX:DA20260409E00100
Canonical exit: 1 Jul 2026 (T+90)
189,500 sharesShareXHKGHKEX:DA20260409E00094
572,500 sharesShareXHKGHKEX:DA20260409E00092
49,000 sharesShareXHKGHKEX:DA20260409E00117
49,000 sharesShareXHKGHKEX:DA20260409E00126
25 of 40 declarations
About Clover Biopharmaceuticals, Ltd. - B
Clover Biopharmaceuticals, Ltd. is a biopharmaceutical company focused on developing vaccines and therapies for infectious diseases. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
